Food & Drug Administration

FDA draft guidelines suggest route to approval for early-stage Alzheimer's drugs

FDA draft guidelines suggest route to approval for early-stage Alzheimer's drugs

By

The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer's drugs.

FDA approves Botox as effective treatment for overactive bladder

By

Botox may be more synonymous with the Real Housewives reality franchise than long-term care residents, but it could soon be a treatment of choice for urinary incontinence.

Hearing loss prevention drugs may be on the way, thanks to new testing method

By

A new method for safely inducing short-term hearing loss in people might be a breakthrough in developing hearing loss prevention drugs, investigators say.

Drug shortage may last for a while

More than 100 medicines now appear on the government's drug shortage list. Those most often in short supply include anesthetics and oncological drugs, according to the Food & Drug Administration. Experts cite several reasons for the ongoing dearth of needed medicines.

Medical device tax could affect long-term care supplies

A medical device excise tax scheduled to hit Jan. 1 is causing uncertainty among manufacturers and providers, a healthcare expert recently noted. The 2.3% tax will affect sales of Food & Drug Administration-approved devices that are used by a physician or in a physician's office.

The disease that keeps on taking

The disease that keeps on taking

By

There is no way to tally the full cost of Alzheimer's disease, a life robbing condition that now claims more than 5 million victims nationwide. But what can be put on a ledger sheet is sobering. Alzheimer's disease is now responsible for a quarter of all claims for nursing home services.

Don't miss any McKnight's news